CVS Health Corporation
CVSNYSEHealthcare● Active
$97.08
+$1.15(+1.20%)
Market Cap$123.9B
P/E Ratio—
52W High$98.43
52W Low$58.5
CVS Health Corporation（CVS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CVS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.73B | $4.59B | $8.37B | $4.33B | $7.99B |
| Depreciation & Amort. | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B |
| Stock-Based Comp. | $0.54B | $0.54B | $0.59B | $0.45B | $0.48B |
| Change in Working Capital | ($1.47B) | $0.11B | $0.01B | $6.82B | $3.86B |
| Net Cash from Operations | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B |
| Investing Activities | |||||
| Capital Expenditure | ($2.83B) | ($2.78B) | ($3.03B) | ($2.73B) | ($2.52B) |
| Purchases of Investments | ($15.01B) | ($15.19B) | ($9.04B) | ($7.75B) | ($9.96B) |
| Sales of Investments | $12.38B | $10.35B | $7.73B | $6.73B | $7.25B |
| Net Cash from Investing | ($5.87B) | ($7.61B) | ($20.89B) | ($5.05B) | ($5.26B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($3.02B) | ($2.01B) | ($3.50B) | $0.00B |
| Dividends Paid | ($3.40B) | ($3.37B) | ($3.13B) | ($2.91B) | ($2.63B) |
| Debt Issued / Repaid | ($3.90B) | $5.06B | $7.93B | ($4.21B) | ($9.27B) |
| Net Cash from Financing | ($4.94B) | ($1.14B) | $2.68B | ($10.52B) | ($11.36B) |
| Free Cash Flow | |||||
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
| FCF Margin %(computed) | 1.94% | 1.70% | 2.91% | 4.17% | 5.39% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解CVS Health Corporation
关于CVS Health Corporation（CVS）现金流量表
CVS Health Corporation 2025财年经营活动现金流$10.64B，自由现金流$7.81B（FCF利润率1.94%），资本支出($2.83B)。
常见问题
CVS · 4 问CVS Health Corporation 2025财年自由现金流$7.81B，同比up23.4%。
CVS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10